Related Experiment Video
Updated: Aug 23, 2025

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
CHA2DS2-VASc score as a prognostic indicator in patients with atrial fibrillation undergoing coronary stenting
Jian-Yong Zheng1, Dong-Tao Li1, Yi-Gang Qıu1
1Department of Cardiology, Division of Cardiology and Cardiovascular Surgery, Sixth Medical Center of PLA General Hospital, Beijing, China.
Insights
The CHA2DS2-VASc score accurately predicts adverse outcomes in patients with atrial fibrillation (AF) and coronary stenting. Higher scores correlate with increased risks of death, stroke, and major adverse cardiac events, confirming its prognostic value.
Area of Science:
- Cardiology
- Clinical Research
- Medical Informatics
Background:
- Patients with atrial fibrillation (AF) and coronary stenting face poor prognoses.
- Assessing predictive accuracy of the CHA2DS2-VASc score in this high-risk population is crucial.
Approach:
- Retrospective review of 2394 patients with nonvalvular AF undergoing coronary stenting (2010-2015).
- Patients stratified into low (≤2), intermediate (3-4), and high (≥5) CHA2DS2-VASc score groups.
- Major adverse cardiac/cerebrovascular events (MACCE) defined as composite of death, myocardial infarction, revascularization, and ischemic stroke/systemic thromboembolism (IS/SE).
Key Points:
- All-cause mortality tripled from low to high CHA2DS2-VASc score groups (4.8% vs. 15.8%).
- High score group (≥5) showed increased IS/SE (7.4%) and MACCE (26.3%).
- CHA2DS2-VASc score ≥5 independently predicted all-cause death (HR 2.303), IS/SE (HR 4.169), and MACCE (HR 1.468).
Conclusions:
- The CHA2DS2-VASc score demonstrates reliability in predicting adverse clinical outcomes for patients with AF and coronary stenting.
- This score aids in risk stratification and management decisions for this vulnerable patient cohort.
Background:
Patients with atrial fibrillation (AF) and coronary stenting had a poor prognosis. This study aimed to assess the accuracy of CHA2DS2-VASc score for predicting and grading adverse clinical outcomes in this population.
Methods:
We reviewed the clinical data of all patients with previously documented nonvalvular AF who underwent coronary stenting between January 2010 and June 2015 in 12 hospitals of Beijing, China. The study population was divided into three groups: 1) Low CHA2DS2-VASc score, ≦ 2 points, 2) Intermediate score, 3-4 points, and 3) High score, ≧ 5 points. Major adverse cardiac/cerebrovascular events (MACCE) were defined as a composite of all-cause death, nonfatal myocardial infarction, repeat revascularization and ischemic stroke/systemic thromboembolism (IS/SE).
Results:
A total of 2394 patients (men: 72.3% vs. women: 27.7%, median age: 67 years) were included, with the CHA2 DS2-VASc score of 3.6 ± 1.6. The median follow-up duration was 36.2 months. All-cause mortality increased 3 folds from the low score (4.8%) to the high score group (15.8%). The high score group had more IS/SE (7.4%) and MACCE (26.3%). The CHA2 DS2-VASc score ≧ 5 points was independently associated with all-cause death (hazard ratio [HR]: 2.303, 95% confidence interval [CI]: 1.492- 3.555), IS/SE (HR: 4.169, 95% CI: 2.216-7.845) and MACCE (HR: 1.468, 95% CI: 1.113-1.936) on multivariate Cox proportional hazards regression. The area under the receiver operating characteristic curve of the CHA2DS2-VASc score was 0.644 (95% CI: 0.624-0.663) for all-cause death, 0.647 (95% CI: 0.627-0.666) for IS/SE, and 0.592 (95% CI: 0.572-0.611) for MACCE.
Discussion:
CHA2DS2-VASc score was a reliable prognostic indicator in patients with AF and coronary stenting.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Mitral Stenosis II: Clinical features and Diagnostic Tests
Heart Failure IV: Classification and Diagnostic Evaluation
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation II: Clinical Features and Diagnostic Tests